Acrodermatitis enteropathica
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
8
|
12
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Cocaine withdrawal
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Opioid use disorder
|
disease |
|
Mental or Behavioral Dysfunction
|
23
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Soft Tissue Infection
|
group |
Infections
|
Disease or Syndrome
|
38
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pelvic Inflammatory Disease
|
group |
Female Urogenital Diseases and Pregnancy Complications; Infections
|
Disease or Syndrome
|
74
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Kashin-Beck Disease
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
77
|
43
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lipoatrophy
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
106
|
6
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Peripheral arterial stenosis
|
disease |
|
Disease or Syndrome
|
124
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Drug usage
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
21
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Iron deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
179
|
13
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Intestinal Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
209
|
13
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Urinary tract infection
|
group |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
219
|
14
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
MRSA - Methicillin resistant Staphylococcus aureus infection
|
disease |
Infections
|
Disease or Syndrome
|
222
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lipodystrophy
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
226
|
28
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2003 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Neural Tube Defects
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Congenital Abnormality
|
304
|
122
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Peripheral Arterial Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
319
|
128
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Microphthalmos
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Congenital Abnormality
|
337
|
40
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Endotoxemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
401
|
5
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Subarachnoid Hemorrhage
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
501
|
26
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Psychotic Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
560
|
179
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mental disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
789
|
149
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
842
|
420
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |